Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 4/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25624155 | 0.92 | MGAM (0.45) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL17190720 | 0.91 | ALDH1A1 (0.41) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL491474 | 0.90 | PRKCA (0.54) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL272764 | 0.88 | TSHR (0.50) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL30531667 | 0.88 | PRKCA (0.45) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL25465012 | 0.87 | MGAM (0.39) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL18089622 | 0.87 | PRKCA (0.47) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL3244216 | 0.86 | TSHR (0.49) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL21815471 | 0.85 | MGAM (0.38) | ALDH1A1LMNAMGAMGAASI | |
| SCHEMBL24119154 | 0.84 | GAA (0.36) | ALDH1A1LMNAMGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 488 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4574871-A1 | CURABLE POLYMER COMPOSITIONS COMPRISING ALDIMINES, POLYISOCYANATES AND COMPOUNDS WITH ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4574867-A1 | CURABLE POLYMER COMPOSITIONS CONTAINING ISOCYANATES, ALDIMINES AND COMPOUNDS HAVING ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | claimed |
| US-11890264-B2 | Migraine prevention and treatment | UNIVERSITATS-KINDERSPITAL BEIDER BASEL (CH) | 2024-02-06 | — | — | US | claimed |
| US-11732165-B2 | Low-temperature curable compositions | EASTMAN CHEMICAL COMPANY (US) | 2023-08-22 | — | — | US | claimed |
| WO-2023139231-A1 | RESIN COMPOSITION | ARXADA AG (CH) | 2023-07-27 | — | — | WO | claimed |
| EP-3662044-B1 | DETERGENT ADDITIVE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-08-03 | — | — | EP | claimed |
| US-11370995-B2 | Detergent additive | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-28 | — | — | US | claimed |
| US-20220056171-A1 | Isocyanate Free Binder | ARXADA AG (CH) | 2022-02-24 | — | — | US | claimed |
| CN-111010876-B | Encapsulation method | 陶氏环球技术有限责任公司 | 2022-01-11 | — | — | CN | claimed |
| CN-110959036-B | Detergent additive | 陶氏环球技术有限责任公司 | 2022-01-04 | — | — | CN | claimed |
| EP-0971989-A1 | NON-POLYMERIC ACETOACETATES AS ADHESION PROMOTING COALESCING AGENTS | EASTMAN CHEMICAL COMPANY (US) | 2000-01-19 | — | — | EP | claimed |
| US-5945489-A | Liquid oligomers containing unsaturation | ASHLAND, INC. (US) | 1999-08-31 | — | — | US | claimed |
| US-5922790-A | ACETOACETATE ESTERS AS ADDED TO WATERBORNE COMPOSITIONS CONTAINING ALKYD RESINS; IMPROVED ADHESION, ESPECIALLY TO CORRODED METAL SUBSTRATES | EASTMAN CHEMICAL COMPANY (US) | 1999-07-13 | — | — | US | claimed |
| WO-1998030639-A1 | NON-POLYMERIC ACETOACETATES AS ADHESION PROMOTING COALESCING AGENTS | EASTMAN CHEMICAL COMPANY (US) | 1998-07-16 | — | — | WO | claimed |
| WO-1996012579-A1 | FOUNDRY MIXES AND THEIR USES | ASHLAND INC. (US) | 1996-05-02 | — | — | WO | claimed |
| US-5459178-A | Aggregate and binder comprising an acetoacetate ester, di-or triacrylate and a liquid tertiary amine catalyst; foundry shapes made by no-bake process | ASHLAND INC. (US) | 1995-10-17 | — | — | US | claimed |
| US-5420335-A | Intravenous feeding | BIRKHAHN RONALD H (US) | 1995-05-30 | — | — | US | claimed |
| WO-1995009144-A1 | NUTRITIVE WATER SOLUBLE GLYCEROL ESTERS OF HYDROXY BUTYRIC ACID | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | claimed |
| WO-1995009146-A1 | PARENTERAL NUTRIENTS BASED ON WATER SOLUBLE GLYCEROL BISACETOACETATES | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | claimed |
| US-5017649-A | Low temperature crosslinking | EASTMAN KODAK COMPANY (US) | 1991-05-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11890264-B2 | Migraine prevention and treatment | ACACA, ACACB, HBB | ALDH1A1 763/4885LMNA 1124/4885MGAM 2155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.